[Rezonizat and cycloserine in complex therapy of drug resistant tuberculosis (comparative studies)].
An open comparative investigation of the Russian drugs rezonizat and cycloserine was performed. The studies made it possible to recommend the use of rezonizat in complex therapy of patients with drug resistant tuberculosis. Higher activity and better tolerability of rezonizat vs. cycloserine was shown.
G B
GB
Sokolova
Ia R
IaR
Lazareva
O V
OV
Kirtaeva
E V
EV
Romanova
A A
AA
Tsybane
D000328:Adult; D000904:Antibiotics, Antitubercular / Q000008:administration & dosage* / Q000009:adverse effects; D003523:Cycloserine / Q000008:administration & dosage* / Q000009:adverse effects; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007555:Isoxazoles / Q000008:administration & dosage* / Q000009:adverse effects; D008297:Male; D008875:Middle Aged; D023303:Oxazolidinones / Q000008:administration & dosage* / Q000009:adverse effects; D018088:Tuberculosis, Multidrug-Resistant / Q000188:drug therapy*; D055815:Young Adult
D000904:Antibiotics, Antitubercular; D007555:Isoxazoles; D023303:Oxazolidinones; C100142:terizidone; D003523:Cycloserine